The Global PuraStat Dinner Grandior Hotel Prague on Thursday 28th April 2022

On Thursday 28th April 2022, 3-D Matrix, in collaboration with FUJIFILM, hosted their first global ...

Meet the Expert in Germany -  PuraStat: Looking Beyond Haemostasis

On the 23rd of February, 3-D Matrix continued its Meet the Expert series with "PuraStat: Looking...

Controlled Trial to Evaluate the Efficacy of PuraStat in Reducing  Delayed Bleeding (in high-risk patients) After Colonic Endoscopic Submucosal Dissection Has Started in France.

The new clinical trial “Multicentre Randomised Controlled Trial (RCT) to assess the efficacy of a...

PuraStat as an effective adjunct therapy for intraprocedural Endoscopic retrograde cholangiopancreatography (ERCP) bleeding: a new case report from Italy.

Endoscopic sphincterotomy is frequently performed during ERCP and bleeding can represent a severe...

Notice regarding the submission for new manufacturing process for haemostatic products in Europe

We are pleased to announce that on the 13th January 2022, our European subsidiary 3-D Matrix Europe...

Prof Di Bartolomeo Chairs 3-D Matrix Cardiac Symposium

On Thursday 14th October 2021, 3-D Matrix hosted a hybrid symposium, ‘Haemostasis in Cardiac Surgery

Study on PuraStat's Efficacy in Liver Resection Bleeding Now Published

New clinical trial data with PuraStat is now available in the publication “A multi-centre...

RCT Study: Exploring Efficacy of PuraStat in EMR Surgeries Goes Live

The clinical trial ‘Colorectal EMR & Delayed Bleeding: Prospective multicentre randomised...

PuraStat: The Impact on Patient Care Now and the Future

On Wednesday 20th October 2021, 3-D Matrix (in partnership with FUJIFILM) hosted its biannual...